Clik here to view.
Cancer drug PAC-1 tested in pet dogs is now bound for human trials
pac 1 Cancer drug tested in pet dogs is now bound for human trials Medical Xpress If PAC-1 (pack one) makes it through the U.S. Food and Drug Administration’s Investigational New Drug review, the...
View ArticleClik here to view.
Curis has obtained the conditional approval for Erivedge (vismodegib) in EU
VISMODEGIB Oncology-focused drug development company Curis has obtained the conditional approval for Erivedge (vismodegib) to treat adult patients with symptomatic metastatic basal cell carcinoma...
View ArticleClik here to view.
Sugammadex sodium-agent for reversal ofneuromuscular blockade by the agent...
Sugammadex sodium Sugammadex (designation Org 25969, tradename Bridion) is an agent for reversal ofneuromuscular blockade by the agent rocuronium in general anaesthesia. It is the firstselective...
View ArticleClik here to view.
Venomous drugs from spiders
Spiders are nature’s pest controllers. These eight-legged, web-forming arachnid predators are equipped with two venom glands full of valuable chemicals designed to kill insect prey. Such compounds,...
View ArticleClik here to view.
Is poor Research the Cause of the Declining productivity of the...
picked up from a japanes site 創薬パラダイム・シフト：プロセス重視からサイエンス重視へ転換せよ Sams-Dodd F. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm...
View ArticleClik here to view.
Phase II trials of TB drug through open source drug discovery programme to...
PA 824 The search for a new tuberculosis drug after many decades and first time through a unique model of open drug discovery programme may finally bear fruits in near future, with India all set for...
View ArticleClik here to view.
Dr Reddy’s Laboratories Ltd-Patent-Preparation of lubiprostone
Dr Reddy’s Laboratories Ltd new patent on Preparation of lubiprostone Jackson, Mark; Dahanukar, Vilas Hareshwar; Joseph, Suju Chuttippari; Eda, Vishnu Vardhana Verma Reddy; Ramdas, Sandip Khobare US...
View ArticleClik here to view.
Diabetes – LX4211
A compound is being investigated as a Type II diabetes treatment by Lexicon Pharmaceuticals, although it is in an early stage of development LX4211 A compound is being investigated as a Type II...
View ArticleClik here to view.
Diabetes – empagliflozin
High blood sugar leads to many long-term complications, including stroke, heart disease, poor circulation, kidney failure and diabetic retinopathy Empagliflozin The rising incidence of Type II...
View ArticleClik here to view.
Sleep disorders – tasimelteon
Melatonin can be used to treat sleep disorders, but it has poor bioavailability, and has a half-life in the body of only about 15 minutes The body’s circadian rhythms – the normal variations in...
View ArticleClik here to view.
Anticancer agent – motesanib
Vascular endothelial growth factor, or VEGF, is often targeted to prevent angiogenesis; When it is overexpressed, rapid tumour growth can result Motesanib A common target for anticancer agents is the...
View ArticleClik here to view.
AstraZeneca began a pivotal trial with selumetinib , thyroid cancer, Phase 3...
selumetinib Array Biopharma To Report Top-line Results From ARRY-502 Asthma Trial Sacramento Bee AstraZeneca began a pivotal trial with selumetinib (an Array-invented drug) in patients with thyroid...
View ArticleClik here to view.
Galapagos Delivers Novel Osteoarthritis Molecules in Alliance with Servier
Galapagos NV announced today the achievement of a late stage discovery milestone for small molecules against a novel target in the osteoarthritis (OA) alliance with Servier....
View ArticleClik here to view.
Probiotic Could Prevent Kidney Stones
The discovery of a gene’s function in E. coli and other bacteria might lead to a probiotic to prevent calcium-oxalate urinary stones, the most common type of kidney stone. Human cells can’t metabolize...
View ArticleClik here to view.
Iron Oxide Nanoparticles Show the Way
Iron oxide nanoparticles precisely direct stem cells to damage tissues, thereby increasing their therapeutic potential Read more...
View ArticleClik here to view.
Health Canada approves two GSK drugs for metastatic melanoma
Health Canada has approved two GlaxoSmithKline (GSK) drugs, Tafinlar(TM) (dabrafenib mesilate) and Mekinist(TM) (trametinib), for patients with unresectable or metastatic melanoma. Dabrafenib...
View ArticleClik here to view.
AstraZeneca: FDA-RESUBMISSION OF THE NDA FOR DAPAGLIFLOZIN FOR THE TREATMENT...
DAPAGLIFLOZIN AstraZeneca and Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA) resubmission for...
View ArticleClik here to view.
Lower your cholesterol naturally
thereare several ways 1 exercise 2 ayurveda 3 diet etc video 1 video 2 video 3
View ArticleClik here to view.
DRUG MANUFACTURING
Anthony crasto manufacturing presentation from ANTHONY MELVIN CRASTO Ph.D
View ArticleClik here to view.
Tesaro begins phase III trial of niraparib for treatment of ovarian cancer
niraparib MK-4827 MK-4827 Formula: C19H20N4O MK-4827 Storage: at -20 ℃ 2 years MK-4827 CAS No.: 1038915-60-4 MK-4827 is an inhibitor of PARP 1 and 2 with IC50 = 3.8 and 2.1 nM, respectively,...
View Article